The impact of curcumin on breast cancer

Integrative Biology (United Kingdom)

Volumn 4, Issue 9, 2012, Pages 996-1007

  Nagaraju, Ganji Purnachandra ^a   Aliya, Sheik ^b   Zafar, Syed F ^a   Basha, Riyaz ^c   Diaz, Roberto ^a   El Rayes, Bassel F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^c M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,7 BIS(4 HYDROXY 3 ETHOXYPHENYL) 1,6 HEPTADIEN 3,5 DIENE; 3,5 BIS(2 FLUOROBENZYLIDENE) 4 PIPERIDINONE; 5 BIS(4 HYDROXY 3 METHOXYBENZYLIDENE) N METHYL 4 PIPERIDINE; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOMYCIN C; NATURAL PRODUCT; PACLITAXEL; PIPERINE; TURMERIC; UNCLASSIFIED DRUG; XANTHORRHIZOL;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BLOOD FLOW; BREAST CANCER; BREAST METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER INHIBITION; CANCER MODEL; CANCER PREVENTION; CANCER RESISTANCE; CELL CYCLE; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION;

EID: 84869887951     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c2ib20088k     Document Type: Review

References (114)

1. A. Jemal F. Bray M. M. Center J. Ferlay E. Ward D. Forman Global cancer statistics Ca-Cancer J. Clin. 2011 61 2 69 90
2. S. Lambrechts J. Decloedt P. Neven Breast cancer prevention: lifestyle changes and chemoprevention Acta Clin. Belg. 2011 66 4 283 292
3. S. Habibovic Z. Hrgovic [BRCA 1 and BRCA 2 gens in breast cancer] Lijec. Vjesn. 1998 120 10-11 342 348
4. M. Hergueta-Redondo J. Palacios A. Cano G. Moreno-Bueno "New" molecular taxonomy in breast cancer Clin. Transl. Oncol. 2008 10 12 777 785
5. R. Dent M. Trudeau K. I. Pritchard W. M. Hanna H. K. Kahn C. A. Sawka et al. Triple-negative breast cancer: clinical features and patterns of recurrence Clin. Cancer Res. 2007 13 15 4429 4434
6. I. Sekine C. Shimizu K. Nishio N. Saijo T. Tamura A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer Int. J. Clin. Oncol. 2009 14 2 112 119
7. J. Kurebayashi Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics Breast Cancer 2009 16 4 275 280
8. P. R. Pohlmann I. A. Mayer R. Mernaugh Resistance to Trastuzumab in Breast Cancer Clin. Cancer Res. 2009 15 24 7479 7491
9. S. Volinia M. Galasso M. E. Sana T. F. Wise J. Palatini K. Huebner et al. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA Proc. Natl. Acad. Sci. U. S. A. 2012 109 8 3024 3029
10. P. de Cremoux [Hormone therapy and breast cancer] Bull. Cancer 2011 98 11 1311 1319
11. B. B. Aggarwal S. Banerjee U. Bharadwaj B. Sung S. Shishodia G. Sethi Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines Biochem. Pharmacol. 2007 73 7 1024 1032
12. H. Itokawa Q. Shi T. Akiyama S. L. Morris-Natschke K. H. Lee Recent advances in the investigation of curcuminoids Chin. Med. 2008 3 1 1 13
13. I. Chattopadhyay K. Biswas U. Bandyopadhyay R. K. Banerjee Turmeric and curcumin: Biological actions and medicinal applications Curr. Sci. 2004 87 1 44 53
14. S. Shishodia G. Sethi B. B. Aggarwal Curcumin: getting back to the roots Ann. N. Y. Acad. Sci. 2005 1056 1 206 217
15. J. Miłobedzka V. Lampe Zur Kenntnis des Curcumins Ber. Dtsch. Chem. Ges. 1910 43 2 2163 2170
16. F. Mohammadi A. K. Bordbar A. Divsalar K. Mohammadi A. A. Saboury Analysis of Binding Interaction of Curcumin and Diacetylcurcumin with Human and Bovine Serum Albumin Using Fluorescence and Circular Dichroism Spectroscopy Protein J. 2009 28 3 189 196
17. P. Anand A. B. Kunnumakkara R. A. Newman B. B. Aggarwal Bioavailability of curcumin: problems and promises Mol. pharmaceutics 2007 4 6 807 818
18. T. M. Kolev E. A. Velcheva B. A. Stamboliyska M. Spiteller DFT and experimental studies of the structure and vibrational spectra of curcumin Int. J. Quantum Chem. 2005 102 6 1069 1079
19. B. B. Aggarwal S. Shishodia Molecular targets of dietary agents for prevention and therapy of cancer Biochem. Pharmacol. 2006 71 10 1397 1421
20. P. K. Shukla V. K. Khanna M. M. Ali M. Y. Khan R. C. Srimal Anti-ischemic effect of curcumin in rat brain Neurochem. Res. 2008 33 6 1036 1043
21. M. Ströfer W. Jelkmann R. Depping Curcumin Decreases Survival of Hep3B Liver and MCF-7 Breast Cancer Cells: The Role of HIF (Original Article) Strahlenther. Onkol. 2011 187 7 393 400
22. H. W. Chen H. C. Huang Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells Br. J. Pharmacol. 1998 124 6 1029 1040
23. B. B. Aggarwal Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals Annu. Rev. Nutr. 2010 30 173 199
24. H. Hatcher R. Planalp J. Cho F. Torti S. Torti Curcumin: from ancient medicine to current clinical trials Cell. Mol. Life Sci. 2008 65 11 1631 1652
25. G. Kuttan, K. B. Hari Kumar, C. Guruvayoorappan and R. Kuttan, Antitumor, anti-invasion, and antimetastatic effects of curcumin, The molecular targets and therapeutic uses of curcumin in health and disease, 2007, pp. 173-184
26. G. Khuwaja M. M. Khan T. Ishrat A. Ahmad S. S. Raza M. Ashafaq et al. Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: Behavioral, neurochemical and immunohistochemical studies Brain Res. 2011 1368 254 263
27. M. Brennan Endocrinology in cancer of the breast. Status and prospects Am. J. Clin. Pathol. 1975 64 6 797 809
28. D. K. Agrawal P. K. Mishra Curcumin and its analogues: Potential anticancer agents Med. Res. Rev. 2010 30 5 818 860
29. R. A. Sharma, W. P. Steward and A. J. Gescher, Pharmacokinetics and pharmacodynamics of curcumin, The molecular targets and therapeutic uses of curcumin in health and disease, 2007, pp. 453-470
30. M. H. Pan T. M. Huang J. K. Lin Biotransformation of curcumin through reduction and glucuronidation in mice Drug Metab. Dispos. 1999 27 4 486 494
31. C. R. Ireson L. R. Kelland Discovery and development of anticancer aptamers Mol. Cancer Ther. 2006 5 12 2957 2962
32. P. Ravindran, K. N. Babu and K. Sivaraman, Turmeric: the genus Curcuma, CRC, 2007, 297-368
33. S. Lev-Ari A. Vexler A. Starr M. Ashkenazy-Voghera J. Greif D. Aderka et al. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines Cancer Invest. 2007 25 6 411 418
34. A. Ślusarz N. S. Shenouda M. S. Sakla S. K. Drenkhahn A. S. Narula R. S. MacDonald et al. Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer Cancer Res. 2010 70 8 3382 3390
35. M. H. Elamin Z. Shinwari S. F. Hendrayani H. Al-Hindi E. Al-Shail A. Al-kofide et al., Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells Mol. Carcinog. 2010 49 3 302 314
36. K. M. Dhandapani V. B. Mahesh D. W. Brann Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFκB transcription factors J. Neurochem. 2007 102 2 522 538
37. A. C. Bharti N. Donato B. B. Aggarwal Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells J. Immunol. 2003 171 7 3863 3871
38. S. Singh B. B. Aggarwal Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane) J. Biol. Chem. 1995 270 42 24995 25000
39. A. B. Kunnumakkara P. Diagaradjane P. Anand H. B. Kuzhuvelil A. Deorukhkar J. Gelovani et al. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model Int. J. Cancer 2009 125 9 2187 2197
40. S. Yodkeeree W. Chaiwangyen S. Garbisa P. Limtrakul Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA J. Nutr. Biochem. 2009 20 2 87 95
41. C. V. Rao A. Rivenson B. Simi B. S. Reddy Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound Cancer Res. 1995 55 2 259 266
42. M. Onoda H. Inano Effect of curcumin on the production of nitric oxide by cultured rat mammary gland Nitric Oxide 2000 4 5 505 515
43. A. P. Zambre V. Kulkarni S. Padhye S. K. Sandur B. B. Aggarwal Novel curcumin analogs targeting TNF-induced NF-[kappa] B activation and proliferation in human leukemic KBM-5 cells Bioorg. Med. Chem. 2006 14 21 7196 7204
44. H. J. Lee, X. Zhang and J. J. Zheng, Inhibiting the Wnt Signaling Pathway with Small Molecules, Targeting the Wnt Pathway in Cancer, 2011, pp. 183-209
45. S. Shankar R. K. Srivastava Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa Carcinogenesis 2007 28 6 1277 1286
46. J. Nautiyal S. Banerjee S. S. Kanwar Y. Yu B. B. Patel F. H. Sarkar et al. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells Int. J. Cancer 2011 128 4 951 961
47. J. W. Lampe Spicing up a vegetarian diet: chemopreventive effects of phytochemicals Am. J. Clin. Nutr. 2003 78 3 579S 583S
48. A. L. Rinaldi M. A. Morse H. W. Fields D. A. Rothas P. Pei K. A. Rodrigo et al. Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo (a) pyrene-7R-trans-7, 8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa Cancer Res. 2002 62 19 5451 5456
49. R. Thapliyal G. Maru Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo Food Chem. Toxicol. 2001 39 6 541 547
50. M. Iqbal S. D. Sharma Y. Okazaki M. Fujisawa S. Okada Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity Pharmacol. Toxicol. 2003 92 1 33 38
51. A. B. Kunnumakkara P. Anand B. B. Aggarwal Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins Cancer Lett. 2008 269 2 199 225
52. C. E. Carroll, M. R. Ellersieck and S. M. Hyder, Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells, Menopause, 2008, vol. 15(3), pp. 570-574
53. D. L. Rowe T. Ozbay R. M. O'Regan R. Nahta Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin Breast Cancer 2009 3 61 75
54. M. Banerjee P. Singh D. Panda Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells FEBS J. 2010 277 16 3437 3448
55. K. Mehta, P. Pantazis, T. McQueen and B. B. Aggarwal, Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines, Anti Cancer Drugs-International Journal on Toxic and Non Toxic Anti Cancer Agents, 1997, vol. 8(5), pp. 470-481
56. M. Bayet-Robert F. Kwiatkowski M. Leheurteur F. Gachon E. Planchat C. Abrial et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer Cancer Biol. Ther. 2010 9 1 8 14
57. R. K. Maheshwari A. K. Singh J. Gaddipati R. C. Srimal Multiple biological activities of curcumin: a short review Life Sci. 2006 78 18 2081 2087
58. T. L. Chiu C. C. Su Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells Int. J. Mol. Med. 2009 23 4 469 475
59. S. Venkiteswaran, T. Sripriya, T. Thomas and T. J. Thomas, Curcumin inhibits the growth of HER-2 overexpressing human breast cancer cells by interference with the glutathione pathway in AACR Meeting Abstracts, 2007, p. 3467
60. J. M. Holy Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells Mutat. Res. 2002 518 1 71 84
61. H. G. Zhang H. Kim C. Liu S. Yu J. Wang W. E. Grizzle et al. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity Biochim. Biophys. Acta, Mol. Cell Res. 2007 1773 7 1116 1123
62. C. P. Prasad G. Rath S. Mathur D. Bhatnagar R. Ralhan Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/[beta]-catenin signaling Chem. - Biol. Interact. 2009 181 2 263 271
63. H. Joensuu P. Bono V. Kataja T. Alanko R. Kokko R. Asola et al. Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial J. Clin. Oncol. 2009 27 34 5685 5692
64. A. M. Stark B. Anuszkiewicz R. Mentlein T. Yoneda H. M. Mehdorn J. Held-Feindt Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells J. Neurooncol. 2007 81 1 39 48
65. N. Ramos-DeSimone E. Hahn-Dantona J. Sipley H. Nagase D. L. French J. P. Quigley Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion J. Biol. Chem. 1999 274 19 13066 13076
66. M. Boonrao S. Yodkeeree C. Ampasavate S. Anuchapreeda P. Limtrakul The inhibitory effect of turmeric curcuminoids on matrix metalloproteinase-3 secretion in human invasive breast carcinoma cells Arch. Pharmacal Res. 2010 33 7 989 998
67. G. Calaf L. B. Smilenov T. K. Pandita T. K. Hei Correlation between telomerase activity and telomere length in human breast epithelial cell lines Science 2011 266 63
68. W. F. Hua Y. S. Fu Y. J. Liao W. J. Xia Y. C. Chen Y. X. Zeng et al. Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells Euro. J. Pharmacol. 2010 637 1 16 21
69. M. J. Yoon E. H. Kim J. H. Lim T. K. Kwon K. S. Choi Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells Free Radicals Biol. Med. 2010 48 5 713 726
70. Y. Xia L. Jin B. Zhang H. Xue Q. Li Y. Xu The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells Life Sci. 2007 80 23 2161 2169
71. N. D. Kim R. Mehta W. Yu I. Neeman T. Livney A. Amichay et al. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer Breast Cancer Res. Treat. 2002 71 3 203 217
72. C. Ramachandran S. Rodriguez R. Ramachandran P. K. R. Nair H. Fonseca Z. Khatib et al. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines Anticancer Res. 2005 25 5 3293 3302
73. S. Sperandio I. de Belle D. E. Bredesen An alternative, nonapoptotic form of programmed cell death Proc. Natl. Acad. Sci. U. S. A. 2000 97 26 14376 14381
74. S. Sperandio K. Poksay I. deBelle M. J. Lafuente B. Liu J. Nasir et al. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix Cell Death Differ. 2004 11 10 1066 1075
75. N. Dhillon B. B. Aggarwal R. A. Newman R. A. Wolff A. B. Kunnumakkara J. L. Abbruzzese et al. Phase II trial of curcumin in patients with advanced pancreatic cancer Clin. Cancer Res. 2008 14 14 4491 4499
76. C. Lao M. Ruffin D. Normolle D. Heath S. Murray J. Bailey et al. Dose escalation of a curcuminoid formulation BMC Complementary Altern. Med. 2006 6 1 10
77. C. Tamvakopoulos K. Dimas Z. D. Sofianos S. Hatziantoniou Z. Han Z. L. Liu et al. Metabolism and anticancer activity of the curcumin analogue Dimethoxycurcumin Clin. Cancer Res. 2007 13 4 1269 1277
78. S. P. Verma B. R. Goldin P. S. Lin The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids Environ. Health Perspect. 1998 106 12 807
79. Y. H. Cheah F. J. Nordin R. Sarip T. T. Tee H. Azimahtol H. M. Sirat et al. Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231 Cancer Cell Int. 2009 9 1
80. L. Hung-Wen, C. Su-Yu, K. Shou-Jen, T. Ling-Ming, L. Hui-Yi and C. Chin-Wen, et al., The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: An In vitro and In vivo Comparison Study with Herceptin, Evidence-Based Complementary and Alternative Medicine, 2012, vol. 2012, pp. 1-12
81. B. B. Aggarwal, C. Sundaram, N. Malani and H. Ichikawa, Curcumin: the Indian solid gold, The molecular targets and therapeutic uses of curcumin in health and disease, 2007, pp. 1-75
82. M. Kakarala L. Rozek M. Cote S. Liyanage D. Brenner Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the US-a SEER analysis BMC Cancer 2010 10 1 191
83. M. H. Teiten, S. Eifes, M. Dicato and M. Diederich, Curcumin - The Paradigm of a Multi-Target Natural Compound with Applications in Cancer Prevention and Treatment, Toxins, 2010, vol. 2(1), pp. 128-162
84. M. Labbozzetta M. Notarbartolo P. Poma A. Maurici L. Inguglia P. Marchetti et al. Curcumin as a Possible Lead Compound against Hormone-Independent, Multidrug-Resistant Breast Cancer Ann. N. Y. Acad. Sci. 2009 1155 1 278 283
85. J. Altenburg A. Bieberich C. Terry K. Harvey J. VanHorn Z. Xu et al. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone BMC Cancer 2011 11 1 149
86. H. Zhou S. C. Beevers S. Huang The targets of curcumin Curr. Drug Targets 2011 12 3 332 347
87. K. A. Furger R. K. Menon A. B. Tuck V. H. C. Bramwell A. F. Chambers The functional and clinical roles of osteopontin in cancer and metastasis Curr. Mol. Med. 2001 1 5 621 632
88. G. Chakraborty S. Jain G. C. Kundu Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms Cancer Res. 2008 68 1 152 161
89. H. I. Kim H. Huang S. Cheepala S. Huang J. Chung Curcumin inhibition of integrin (α6β4)-dependent breast cancer cell motility and invasion Cancer Prev. Res. 2008 1 5 385 391
90. B. K. Adams E. M. Ferstl M. C. Davis M. Herold S. Kurtkaya R. F. Camalier et al. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents Bioorg. Med. Chem. 2004 12 14 3871 3883
91. H. Ohori H. Yamakoshi M. Tomizawa M. Shibuya Y. Kakudo A. Takahashi et al. Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer Mol. Cancer Ther. 2006 5 10 2563 2571
92. W. M. Weber L. A. Hunsaker C. N. Roybal E. V. Bobrovnikova-Marjon S. F. Abcouwer R. E. Royer et al. Activation of NF [kappa] B is inhibited by curcumin and related enones Bioorg. Med. Chem. 2006 14 7 2450 2461
93. M. Yousef Elahi H. Heli S. Bathaie M. Mousavi Electrocatalytic oxidation of glucose at a Ni-curcumin modified glassy carbon electrode J. Solid State Electrochem. 2007 11 2 273 282
94. S. Padhye S. Banerjee D. Chavan S. Pandye K. V. Swamy S. Ali et al. Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice Pharm. Res. 2009 26 11 2438 2445
95. Y. Sugiyama S. Kawakishi T. Osawa Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin Biochem. Pharmacol. 1996 52 4 519 525
96. E. M. Al-Hujaily A. G. Mohamed I. Al-Sharif K. M. Youssef P. S. Manogaran B. Al-Otaibi et al. PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells Breast Cancer Res. Treat. 2011 128 97 107
97. J. R. Fuchs B. Pandit D. Bhasin J. P. Etter N. Regan D. Abdelhamid et al. Structure-activity relationship studies of curcumin analogues Bioorg. Med. Chem. Lett. 2009 19 7 2065 2069
98. J. Ishida H. Ohtsu Y. Tachibana Y. Nakanishi K. F. Bastow M. Nagai et al. Antitumor Agents. Part 214:+ Synthesis and Evaluation of Curcumin Analogues as Cytotoxic Agents Bioorg. Med. Chem. 2002 10 11 3481 3487
99. S. Venkateswarlu M. S. Ramachandra G. V. Subbaraju Synthesis and biological evaluation of polyhydroxycurcuminoids Bioorg. Med. Chem. 2005 13 23 6374 6380
100. C. C. Lin H. Y. Lin H. C. Chen M. W. Yu M. H. Lee Stability and characterisation of phospholipid-based curcumin-encapsulated microemulsions Food Chem. 2009 116 4 923 928
101. M. A. Bill J. R. Fuchs C. Li J. Yui C. Bakan D. M. Benson et al. The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity Mol. Cancer 2010 9 1 165
102. H. Shibata H. Yamakoshi A. Sato H. Ohori Y. Kakudo C. Kudo et al. Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo Cancer Sci. 2009 100 5 956 960
103. B. K. Adams J. Cai J. Armstrong M. Herold Y. J. Lu A. Sun et al. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism Anti-cancer drugs. 2005 16 3 263 275
104. A. L. Kasinski Y. Du S. L. Thomas J. Zhao S. Y. Sun F. R. Khuri et al. Inhibition of IκB kinase-nuclear factor-κB signaling pathway by 3, 5-bis (2-flurobenzylidene) piperidin-4-one (EF24), a novel monoketone analog of curcumin Mol. Pharmacol. 2008 74 3 654 661
105. M. Shoji A. Sun W. Kisiel Y. J. Lu H. Shim B. E. McCarey et al. Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa J. Drug Targeting 2008 16 3 185 197
106. S. L. Thomas D. Zhong W. Zhou S. Malik D. Liotta J. P. Snyder et al. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1 Cell Cycle 2008 7 15 2409 2417
107. M. Sun Z. Estrov Y. Ji K. R. Coombes D. H. Harris R. Kurzrock Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells Mol. Cancer Ther. 2008 7 3 464 473
108. R. M. DeBusk Dietary supplements and cardiovascular disease Curr. Atheroscler. Rep. 2000 2 6 508 514
109. S. Kawanishi S. Oikawa M. Murata Evaluation for safety of antioxidant chemopreventive agents Antioxid. Redox signaling 2005 7 11-12 1728 1739
110. S. Somasundaram N. A. Edmund D. T. Moore G. W. Small Y. Y. Shi R. Z. Orlowski Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer Cancer Res. 2002 62 13 3868 3875
111. R. Somasundaram L. Jacob R. Swoboda L. Caputo H. Song S. Basak et al. Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-β Cancer Res. 2002 62 18 5267 5272
112. M. Ströfer W. Jelkmann E. Metzen U. Brockmeier J. Dunst R. Depping Stabilisation and Knockdown of HIF-Two Distinct Ways Comparably Important in Radiotherapy Cell. Physiol. Biochem. 2011 28 5 805 812
113. M. M. Yallapu D. M. Maher V. Sundram M. C. Bell M. Jaggi S. C. Chauhan Research Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth J. Ovarian Res. 2010 3 11
114. C. Mohanty S. K. Sahoo The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 2010 31 25 6597 6611